Clinical Trial

Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 4, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
Randomized, double-blind, parallel, placebo-controlled clinical trial designed and conducted to evaluate the effect of daily consumption of ginger, on parameters related to inflammation, oxidative stress, and endothelial damage in adults with excess adiposity.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-19; most recent amendment 2026-03-02.
Status change: Not Yet Recruiting → Recruiting 2026-03-02
Trial Details
NCT Number NCT07433998
Lead Sponsor Javier Marhuenda
Conditions Inflammation Biomarkers, Oxidative Stress, Cardiometabolic Risk Factors
Enrollment 50 participants
Start Date 2026-03
Primary Completion 2026-05 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-04